Pharvaris holder plans $765K sale of 20,000 shares

Rhea-AI Filing Summary

Pharvaris N.V. (PHVS) is the issuer of common shares that a shareholder affiliated with Graymatters Consulting plans to sell under Rule 144. The notice covers up to 20,000 common shares to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services, with an indicated value of $765,466.00 and an intended sale date of September 17, 2026 on NASDAQ.

In the preceding three months, persons associated with the same address, including Anne Lesage and Graymatters Consulting B.V., reported several open-market sales of Pharvaris common shares, such as 30,000 shares on September 10, 2026 for $1,149,084.00 and 30,703 shares on June 30, 2026 for $1,089,637.19.

Key Figures

Shares to be sold under Rule 144: 20,000 shares Proposed sale value: $765,466.00 Recent sale by Anne Lesage: 30,000 shares for $1,149,084.00 +3 more

6 metrics

Shares to be sold under Rule 144 20,000 shares Pharvaris N.V. common shares covered by the current Form 144 notice

Proposed sale value $765,466.00 Indicated value for 20,000 Pharvaris N.V. common shares to be sold on September 17, 2026

Recent sale by Anne Lesage 30,000 shares for $1,149,084.00 Common shares sold on September 10, 2026

Recent sale by Graymatters Consulting B.V. 30,703 shares for $1,089,637.19 Common shares sold on June 30, 2026

Additional sale by Anne Lesage 27,872 shares for $988,890.66 Common shares sold on June 30, 2026

Smaller June 29 and June 25 sales 19,897 shares for $697,699.44 Aggregate of multiple Pharvaris common share sales listed for June 29 and June 25, 2026

Key Terms

Rule 144, Founder Shares, Founder Stock

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Founder Shares financial

"144: Securities To Be Sold Founder Shares | 12/31/2016 | Founder Stock"

Founder shares are the ownership stakes given to the people who start a company, often with extra voting power or protections compared with ordinary shares. For investors, they matter because founders’ control and incentives influence decisions about strategy, hiring, and whether the company sells or stays independent — like a family that keeps majority voting rights in a household decision. High founder ownership can mean stable leadership but also a risk that outside shareholders have less influence.

Founder Stock financial

"144: Securities To Be Sold Founder Shares | 12/31/2016 | Founder Stock"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing for PHVS disclose?

It discloses that a shareholder for whose account Graymatters Consulting is acting intends to sell up to 20,000 Pharvaris N.V. common shares under Rule 144 through Morgan Stanley Smith Barney LLC Executive Financial Services, with an indicated value of $765,466.00.

How many PHVS shares are planned to be sold in this Form 144?

The notice covers a proposed sale of 20,000 common shares of Pharvaris N.V. These are described as being held as Founder Shares and are planned for sale through Morgan Stanley Smith Barney LLC Executive Financial Services.

What recent PHVS share sales are reported in the past three months?

The filing lists several past sales, including 30,000 shares sold by Anne Lesage on September 10, 2026 for $1,149,084.00, and 30,703 shares sold by Graymatters Consulting B.V. on June 30, 2026 for $1,089,637.19, along with several smaller transactions in late June 2026.

Who is the broker for the planned PHVS share sale?

The proposed sale of 20,000 Pharvaris N.V. common shares will be executed through Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, New York, as stated in the Form 144 filing.

On which market are the PHVS shares in this filing to be sold?

The Form 144 states that the 20,000 Pharvaris N.V. common shares covered by the notice are intended to be sold on NASDAQ, with an intended sale date of September 17, 2026.

What type of Pharvaris securities are being sold under Rule 144?

The securities are described as Founder Shares of Founder Stock in Pharvaris N.V., held by the person for whose account Graymatters Consulting is acting, with 20,000 shares noted as to be sold under Rule 144.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/17/2026 - 04:28 PM Accepted by SEC EDGAR 09/17/2026 - 04:28 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001973705
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	PHARVARIS N.V.
SEC File Number	001-40010
Address of Issuer	Emmy Noetherweg 2 Leiden NETHERLANDS 2333 BK
Phone	31 (0)71 2036 410
Name of Person for Whose Account the Securities are To Be Sold	GRAYMATTERS CONSULTING
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	20000	765466.00	70204506	09/17/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Founder Shares	12/31/2016	Founder Stock	Issuer			20000	12/31/2016	Founder Shares

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
ANNE LESAGE Emmy Noetherweg 2 Leiden P7 2333 BK	Common	09/10/2026	30000	1149084.00
GRAYMATTERS CONSULTING B.V. Emmy Noetherweg 2 Leiden P7 2333 BK	Common	06/30/2026	30703	1089637.19
ANNE LESAGE Emmy Noetherweg 2 Leiden P7 2333 BK	Common	06/30/2026	27872	988890.66
ANNE LESAGE Emmy Noetherweg 2 Leiden P7 2333 BK	Common	06/29/2026	8300	290907.83
GRAYMATTERS CONSULTING B.V. Emmy Noetherweg 2 Leiden P7 2333 BK	Common	06/29/2026	6997	245231.56
ANNE LESAGE Emmy Noetherweg 2 Leiden P7 2333 BK	Common	06/25/2026	2300	80774.46
GRAYMATTERS CONSULTING B.V. Emmy Noetherweg 2 Leiden P7 2333 BK	Common	06/25/2026	2300	80785.59

144: Remarks and Signature

Remarks
Date of Notice	09/17/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Anne Simone Lesage
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)